Skip to main content
. 2024 Feb 25;115(4):1296–1305. doi: 10.1111/cas.16107

FIGURE 1.

FIGURE 1

ORR of tepotinib in Japanese patients according to baseline characteristics. *Smoking history was missing for one patient. Seven patients had histology other than squamous and adenocarcinoma. Identified at baseline (investigator or independent review). 1L, first line; 2L, second line; 2L+, second‐or‐later line; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status; METex14, MET exon 14; ORR, objective response rate.